Abstract: An apparatus that comprises a plurality of memory cells and a control circuit coupled to the plurality of memory cells is disclosed. The control circuit is configured to perform a read operation. The read operation includes determining a read condition of a memory cell, where the read condition is of a plurality of read conditions and determining a boost timing for the memory cell, where the boost timing corresponds to the read condition.

Abstract: A display image filling method includes filling a plurality of first invalid points in disparity image data to generate first image data, and filling a plurality of second invalid points in the first image data to generate second image data. The first invalid points are filled by searching for valid points in the disparity image data according to a first step size, and the second invalid points are filled by searching for the valid points in the first image data according to a second step size, wherein the first step size is smaller than the second step size.

Abstract: The present invention relates to a computer-implemented method for electrocardiogram analysis, the method comprising the steps of receiving at least one ECG signal; analyzing the ECG signal to provide features and/or identify at least one episode and/or event, wherein an episode is a segment of the ECG signal defined by a starting time, a duration and a label obtained during the analysis of the ECG signal and an event is a strip of the ECG signal of predefined duration defined by a starting time and a label obtained during the analysis of the ECG signal; and displaying a multiple field display (1) which includes at least a main plot (42), being a global view of a graphic representation of the ECG signal in a first time window; a local view of a graphic representation of the ECG signal in a second time window (51), where the first time window comprises the second time window; an intermediate view of a graphic representation of the ECG signal in a third time window (52), wherein the third time window comprises

Abstract: The present disclosure provides a photo-curable elastic ink composition for three-dimensional printing and the preparation method. The ink composition includes approximately 10%-75% of a soft monomer, approximately 10%-75% of a hard monomer, approximately 5%-20% of a cross-linking agent, approximately 5%-20% of a non-reactive soft resin, approximately 0.5%-10% of a photo-initiator, approximately 0%-0.5% of a colorant, and approximately 0.05%-8% of an auxiliary agent. The soft monomer is capable of generating a homopolymer with a glass transition temperature lower than about 25° C. The hard monomer is capable of generating a homopolymer with a glass transition temperature of about 25° C. or higher. The non-reactive soft resin is a resin without containing any radiation curable group in the molecular structure and having a glass transition temperature less than 0° C.

Abstract: Systems, methods, devices, media, and computer readable instructions are described for local image tagging in a resource constrained environment. One embodiment involves processing image data using a deep convolutional neural network (DCNN) comprising at least a first subgraph and a second subgraph, the first subgraph comprising at least a first layer and a second layer, processing, the image data using at least the first layer of the first subgraph to generate first intermediate output data; processing, by the mobile device, the first intermediate output data using at least the second layer of the first subgraph to generate first subgraph output data, and in response to a determination that each layer reliant on the first intermediate data have completed processing, deleting the first intermediate data from the mobile device. Additional embodiments involve convolving entire pixel resolutions of the image data against kernels in different layers if the DCNN.

Abstract: Disclosed are a compound of formula (I), a stereoisomer, a pharmaceutically acceptable salt, a solvate, and a eutectic or deuterated compound thereof, or a pharmaceutical composition comprising same, and a use thereof as an EZH2 inhibitor in the preparation of a medication for treating related diseases. The definition of each group in formula (I) is consistent with that in the description.

Abstract: A communication method and apparatus are provided. The communication apparatus communicates with a device to obtain first information that includes location information and/or motion information of the device, and senses an environment to obtain environment sensing information that includes location information and/or motion information of an object in the environment. The communication apparatus determines a first antenna panel and/or a second antenna panel different from the first antenna panel based on the first information and the environment sensing information, where the first antenna panel is configured to communicate with a first device, and/or is configured to send, to the first device, a signal for sensing information, the second antenna panel is configured to receive sensing signal from the first device. In the communication apparatus, sensing and communication functions can be implemented in a single hardware system, thereby decreasing a size of the communication apparatus and reducing the cost.

Abstract: Apparatuses, systems, and methods for a wireless device to perform methods to implement mechanisms for a UE to request a beam quality measurement procedure. A user equipment device may be configured to perform a method including performing transmitting a request to perform a beam quality measurement procedure for downlink receptions (e.g., a P3 procedure) to a base station/network entity, receiving instructions to perform the beam quality measurement procedure from the base station, and transmitting results of the beam quality measurement procedure to the base station. In some embodiments, transmission of the request may be response to at least one trigger condition and/or detection of a condition at the UE. The request may include an indication of a preferred timing offset. The instructions to perform the beam quality measurement procedure may include a schedule for the beam quality measurement.

Abstract: The present invention relates to the technical field of medicines, and relates to a polyethylene glycol conjugated drug, a preparation method therefor and the use thereof. In particular, the present invention relates to a polyethylene glycol conjugated drug as shown in formula I or a pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the polyethylene glycol conjugated drug or the pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the polyethylene glycol conjugated drug or the pharmaceutically acceptable salt thereof, and the use thereof in the preparation of a drug.

Abstract: The present disclosure relates to a multilayer composite that may include a first porous layer, and a first barrier layer overlying the first porous layer. The first barrier layer may include a polyaramid material, a polyimide material, or any combination thereof. The multilayer composite may have a flame resistance rating of at least about 180° C. and a 50% strain compression rating of not greater than about 600 kPa.

Abstract: A strong FXR small-molecule agonist, and a preparation method therefor and use thereof, the structure of the agonist being represented by formula (I), are provided. In the formula, each substituent is as defined in the description and the claims. The compound provided has the advantages of high FXR agonist activity, simple synthesis, easily available raw materials and the like, and can be used for preparing medicines for treating FXR related diseases.

Abstract: A compound as shown in general formula B-L-K (I) or stereoisomers, deuterated compounds, solvates, prodrugs, metabolites, pharmaceutically acceptable salts or co-crystals thereof, and intermediates thereof and uses thereof for AR-related diseases such as prostate cancer.

Abstract: A battery cell, a battery module, a battery pack, and an electrical apparatus are provided. The battery cell includes an intermediate portion and side portions located on two sides of the intermediate portion in a thickness direction, the intermediate portion comprising m battery cell sub-units and the side portions comprising n battery cell sub-units, where m+n is an integer greater than or equal to 3. Each of the battery cell sub-units comprises a positive electrode sheet, a negative electrode sheet and a separator arranged between the positive electrode sheet and the negative electrode sheet, and each of the m battery cell sub-units has a dry battery cell nail penetration short-circuit resistance greater than that of each of the n battery cell sub-units.

Abstract: Disclosed is a nitrile derivative compound represented by formula (I), a stereoisomer, a deuterated product, a co-crystal, a solvate or a pharmaceutically acceptable salt thereof, wherein each group is as defined in the description. The compound has dipeptidyl peptidase 1 inhibitory activity and can be used to prepare a drug for treating diseases including obstructive airway diseases, bronchiectasis, cystic fibrosis, asthma, emphysema, and chronic obstructive pulmonary diseases.

Abstract: A growth-promoting bacterial agent capable of improving content of soybean oil, preparation method, and use thereof are provided. The growth-promoting bacterial agent is fermented by a DW1 strain, the classification name of the DW1 strain is Bacillus sp., the DW1 strain is deposited in the China Center for Type Culture Collection on Jul. 16, 2021, and the deposit number is CCTCC NO: M 2021889. The growth-promoting bacterial agent of the present disclosure has the ability to dissolve insoluble phosphorus and insoluble potassium and can increase content of readily available phosphorus and readily available potassium in the soil, which has an obvious promoting effect on the growth of soybean and improves soybean yield. The growth-promoting bacterial agent of the present disclosure promotes bacteria and can significantly improve the content of soybean oil. At the same time, it has an affinity of soybean agglutinin and can agglutinate with the soybean agglutinin.

Abstract: A type of Bruton's tyrosine kinase inhibitor, a preparation method therefor, and an application thereof in the field of medicine. The Bruton's tyrosine kinase inhibitor may be used for preventing and/or treating a disease related to Bruton's tyrosine kinase mediation, such as an autoimmune disease, cancer, or an inflammatory disease. Through experimental research, the provided compound has high selectivity with respect to a Bruton's tyrosine kinase target, and can exhibit a uniquely advantageous medicinal effect in an in vivo animal experiment.

Abstract: A positive electrode current collector and a positive electrode plate, a battery, a battery module, a battery pack, and an apparatus including the positive electrode current collector are provided. In some embodiments, a positive electrode current collector is provided, including an organic support layer and an aluminum-based conductive layer disposed on at least one surface of the organic support layer, where the aluminum-based conductive layer contains Al and at least one modifying element selected from O, N, F, B, S, and P, an XPS spectrogram of the aluminum-based conductive layer with a surface passivation layer removed through etching has at least a first peak falling in a range of 70 eV to 73.5 eV and a second peak falling in a range of 73.5 eV to 78 eV, and a ratio x of peak intensity of the second peak to that of the first peak satisfies 0<x?3.0.

Abstract: Embodiments of the present disclosure relate to a method, system, and computer program product for dynamic update of a computer program in memory. According to the method, one or more processors obtain incremental information, the incremental information specifying an incremental update to at least one section of at least one target function in a computer program. One or more processors identify, based on the incremental information, the at least one target function to be updated from the computer program. One or more processors generate at least one updated copy of the at least one target function by updating the at least one section of the at least one target function based on the incremental information. One or more processors update the computer program based on the at least one updated copy of the at least one target function while the computer program is running.

Abstract: The present invention relates to a polyethylene glycol conjugate medicament, a preparation method therefor and use thereof, and in particular relates to a polyethylene glycol conjugate medicament represented by formula (I) or a pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the polyethylene glycol conjugate medicament or a pharmaceutically acceptable salt thereof, and an intermediate of the same, a pharmaceutical composition comprising the polyethylene glycol conjugate medicament or a pharmaceutically acceptable salt thereof, and use thereof in preparing a medicament.